Literature DB >> 15641101

Mature dendritic cells readily break tolerance in normal mice but do not lead to disease expression.

Maria Georgiev1, Lucila M A Agle, Jia Li Chu, Keith B Elkon, Dalit Ashany.   

Abstract

OBJECTIVE: To examine the ability of mature dendritic cells (DCs) or macrophages intentionally exposed to lipopolysaccharide or apoptotic or necrotic cells to break tolerance in normal mice.
METHODS: We adoptively transferred into C57BL/6 mice a variety of syngeneic myeloid antigen-presenting cell populations exposed to different activation stimuli as well as to meals of necrotic and apoptotic cells. We studied expression of autoimmunity in the immunized mice by serologic evaluation of autoantibody production, subclass analysis of Ig production, clinical evidence of kidney disease, glomerular immune complex deposition, and renal pathology.
RESULTS: Injection of mice with DCs incubated with apoptotic or necrotic cells, as well as, surprisingly, with DCs cultured in media alone, induced high levels of IgG autoantibodies, including anti-double-stranded DNA (anti-dsDNA) antibodies. In striking contrast, transfer of equivalent-treated macrophages failed to generate IgG autoantibodies. IgG was deposited in the kidneys of mice vaccinated with DCs, but despite high levels of anti-dsDNA antibodies, these mice did not develop overt nephritis. Serologic evaluation of the antibody response revealed that the mice primarily developed elevated levels of IgG1 antibodies, including high levels of IgG1 anti-dsDNA.
CONCLUSION: The data suggest that mature myeloid DCs are able to break tolerance and induce lupus autoantibodies in normal hosts, but that other susceptibility factors must be in place to induce long-lasting autoimmunity and clinical expression of disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15641101     DOI: 10.1002/art.20759

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  18 in total

Review 1.  Apoptotic cell death and lupus.

Authors:  Philip L Cohen
Journal:  Springer Semin Immunopathol       Date:  2006-08-29

Review 2.  Dendritic cells: potential triggers of autoimmunity and targets for therapy.

Authors:  J A Hardin
Journal:  Ann Rheum Dis       Date:  2005-11       Impact factor: 19.103

3.  Autoimmunity stimulated by adoptively transferred dendritic cells is initiated by both alphabeta and gammadelta T cells but does not require MyD88 signaling.

Authors:  David A Martin; Kang Zhang; Justin Kenkel; Grant Hughes; Edward Clark; Anne Davidson; Keith B Elkon
Journal:  J Immunol       Date:  2007-11-01       Impact factor: 5.422

Review 4.  Contribution of dendritic cells to the autoimmune pathology of systemic lupus erythematosus.

Authors:  Juan P Mackern-Oberti; Carolina Llanos; Claudia A Riedel; Susan M Bueno; Alexis M Kalergis
Journal:  Immunology       Date:  2015-10-12       Impact factor: 7.397

Review 5.  Kidney dendritic cells in acute and chronic renal disease.

Authors:  Katharina Hochheiser; André Tittel; Christian Kurts
Journal:  Int J Exp Pathol       Date:  2010-07-30       Impact factor: 1.925

6.  Immunization with an apoptotic cell-binding protein recapitulates the nephritis and sequential autoantibody emergence of systemic lupus erythematosus.

Authors:  Jerrold S Levine; Rebecca Subang; Samih H Nasr; Sylvie Fournier; Ginette Lajoie; Joan Wither; Joyce Rauch
Journal:  J Immunol       Date:  2006-11-01       Impact factor: 5.422

7.  Cutting Edge: Induction of Inflammatory Disease by Adoptive Transfer of an Atypical NK Cell Subset.

Authors:  Elisaveta Voynova; Chen-Feng Qi; Bethany Scott; Silvia Bolland
Journal:  J Immunol       Date:  2015-06-24       Impact factor: 5.422

8.  Increased ribonuclease expression reduces inflammation and prolongs survival in TLR7 transgenic mice.

Authors:  Xizhang Sun; Alice Wiedeman; Nalini Agrawal; Thomas H Teal; Lena Tanaka; Kelly L Hudkins; Charles E Alpers; Silvia Bolland; Matthew B Buechler; Jessica A Hamerman; Jeffrey A Ledbetter; Denny Liggitt; Keith B Elkon
Journal:  J Immunol       Date:  2013-02-04       Impact factor: 5.422

Review 9.  Molecular control of steady-state dendritic cell maturation and immune homeostasis.

Authors:  Gianna Elena Hammer; Averil Ma
Journal:  Annu Rev Immunol       Date:  2013-01-17       Impact factor: 28.527

10.  Cancer immunotherapy using dendritic/tumour-fusion vaccine induces elevation of serum anti-nuclear antibody with better clinical responses.

Authors:  S Homma; Y Sagawa; M Ito; T Ohno; G Toda
Journal:  Clin Exp Immunol       Date:  2006-04       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.